Atara Biotherapeutics Ratios (2021-2026) | ATRA

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 100.00%100.00%100.00%82.38%-265.07%-22.31%35.19%92.74%83.84%81.08%79.25%79.18%96.85%96.67%93.48%75.97%
EBT Margin (Quarter) -1,204.61%35.80%-33,789.59%-6,096.98%-8,966.83%-3,265.48%-1,244.63%-115.98%-66.51%-54.56%-38.81%38.73%13.60%-123.81%-2,266.02%-803.29%
EBIT Margin (Quarter) -1,206.18%-62.30%-34,180.54%-6,118.92%-9,005.55%-3,255.94%-1,229.74%-114.22%-63.66%-54.14%-37.26%39.53%18.19%-103.50%-1,978.31%-652.91%
EBITDA Margin (Quarter) -1,225.44%34.39%-33,339.37%-6,031.08%-8,928.63%-3,247.66%-1,232.22%-115.52%-66.37%-54.42%-38.80%38.72%13.58%-124.56%-213.61%-803.49%
Operating Margin (Quarter) -1,206.18%-62.30%-34,180.54%-6,118.92%-9,005.55%-3,255.94%-1,229.74%-114.22%-63.66%-54.14%-37.26%39.53%18.19%-103.50%-1,978.31%-652.91%
Net Margin (Quarter) -1,204.61%35.80%-33,790.50%-6,098.78%-8,966.96%-3,264.59%-1,244.85%-116.07%-66.51%-54.51%-38.75%38.73%13.58%-124.62%-2,266.02%-803.29%
FCF Margin (Quarter) -1,171.96%-121.96%-25,749.32%-3,167.05%-6,621.06%-2,397.47%-1,036.05%-108.71%-37.27%-9.93%-74.99%-28.67%-41.64%-283.43%-357.18%-595.54%
Efficiency
Inventory Average (Quarter) 3.46M6.60M7.23M8.15M12.89M17.42M16.36M12.32M
Assets Average (Quarter) 432.70M416.70M402.22M372.37M339.25M274.26M217.61M177.15M165.39M141.28M130.00M125.90M85.57M49.47M33.53M25.20M20.12M
Equity Average (Quarter) 251.97M240.90M222.30M156.88M95.80M36.21M-21.69M24.20M0.46M-104.59M-100.70M-93.91M-76.18M-45.06M-35.84M-37.57M-37.91M
Invested Capital (Quarter) 279.61M224.32M257.48M187.11M126.64M64.96M7.45M-50.84M99.23M-98.31M-110.87M-90.54M-97.28M-55.07M-35.04M-36.63M-38.50M-37.31M
Asset Utilization Ratio (Quarter) 0.160.160.010.020.050.210.450.781.022.333.814.534.791.15
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.02M-249.09-687.98-645.63-56.15-51.82-49.90-50.99-27.10-14.45-18.39-12.0038.153.29-3.93-35.30-4.06
Equity Ratio (Quarter) 0.600.560.590.510.340.220.03-0.270.60-0.59-0.95-0.63-0.89-0.89-0.95-1.21-1.90-1.87
Times Interest Earned (Quarter) -0.02M-249.09-687.98-645.63-56.15-51.82-49.90-50.99-27.10-14.45-18.39-12.0038.153.29-3.93-35.30-4.06
Valuation
Enterprise Value (Quarter) -371.07M-101.81M-72.03M-265.40M-242.82M-48.89M-46.04M-64.94M-51.73M-35.23M-35.29M-67.19M-25.18M-13.84M-16.90M-13.71M-8.50M-8.40M
Return Ratios
Return on Sales (Quarter) -0.12%0.00%-3.38%-0.61%-0.90%-0.33%-0.12%-0.01%-0.01%-0.01%0.00%0.00%0.00%-0.01%-0.23%-0.08%
Return on Capital Employed (Quarter) -95.59%-98.50%-153.52%-210.49%-790.40%1,517.68%2,561.91%504.91%962.15%-35.54%23.03%169.42%66.85%-243.94%
Return on Invested Capital (Quarter) -0.02%-0.03%-0.08%0.13%-0.11%-5.03%0.02%0.01%0.01%0.00%0.00%-0.01%0.00%0.01%
Return on Assets (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.01%0.00%-0.02%
Return on Equity (Quarter) -0.01%-0.01%-0.02%-0.08%0.13%-0.11%-5.06%0.02%0.01%0.01%0.00%0.00%-0.01%0.00%0.01%